BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/26/2025 10:27:35 AM | Browse: 3 | Download: 1
Publication Name World Journal of Hepatology
Manuscript ID 110966
Country United Kingdom
Received
2025-06-20 02:06
Peer-Review Started
2025-06-20 02:06
First Decision by Editorial Office Director
2025-07-08 09:25
Return for Revision
2025-07-08 09:25
Revised
2025-08-13 14:17
Publication Fee Transferred
Second Decision by Editor
2025-12-03 02:42
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2025-12-03 05:42
Articles in Press
2025-12-03 05:42
Edit the Manuscript by Language Editor
Typeset the Manuscript
2025-12-18 01:02
Publish the Manuscript Online
2025-12-26 10:27
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Health Care Sciences & Services
Manuscript Type Minireviews
Article Title Refractory autoimmune hepatitis in children: Considerations for assessment and management
Manuscript Source Invited Manuscript
All Author List Joseph Valamparampil, Rachel M Brown and Patrick Mckiernan
ORCID
Author(s) ORCID Number
Joseph Valamparampil http://orcid.org/0000-0002-8114-2523
Rachel M Brown http://orcid.org/0000-0001-5395-8456
Funding Agency and Grant Number
Corresponding Author Joseph Valamparampil, MD, Liver unit (including small bowel transplantation), Birmingham Women’s and Children's NHS Foundation Trust, Steel house Lane, Birmingham B4 6NH, United Kingdom. joseph.valam@nhs.net
Key Words Autoimmune hepatitis; Refractory; Remission; Treatment; Non-compliance
Core Tip Treatment of autoimmune hepatitis seeks to induce and maintain remission, prevent progression, and potentially reverse fibrosis. In the 10%-20% of children unresponsive to steroids and azathioprine, adherence to medication and diagnosis should be reassessed and mimicking diseases excluded. Mycophenolate mofetil is the preferred second-line agent. Further therapy should be individualized, with adjustments made only after 6-12 months.
Publish Date 2025-12-26 10:27
Citation

Valamparampil J, Brown RM, Mckiernan P. Refractory autoimmune hepatitis in children: Considerations for assessment and management. World J Hepatol 2025; 17(12): 110966

URL https://www.wjgnet.com/1948-5182/full/v17/i12/110966.htm
DOI https://dx.doi.org/10.4254/wjh.v17.i12.110966
Full Article (PDF) WJH-17-110966-with-cover.pdf
Manuscript File 110966_Auto_Edited_034432.docx
Answering Reviewers 110966-answering-reviewers.pdf
Audio Core Tip 110966-audio.m4a
Conflict-of-Interest Disclosure Form 110966-conflict-of-interest-statement.pdf
Copyright License Agreement 110966-copyright-assignment.pdf
Peer-review Report 110966-peer-reviews.pdf
Scientific Misconduct Check 110966-scientific-misconduct-check.png
Scientific Editor Work List 110966-scientific-editor-work-list.pdf
CrossCheck Report 110966-crosscheck-report.pdf